Prices · Refractive · Presbyopic ICL · Updated May 2026
Private EVO Viva presbyopic ICL cost, UK 2026
EVO Viva is the STAAR Surgical extended depth of focus (EDOF) phakic implantable collamer lens designed for presbyopic patients in their late 40s and 50s who want distance and functional intermediate vision without removing the natural crystalline lens and without laser ablation of the cornea.
Unlike a refractive lens exchange that swaps the natural lens for a multifocal IOL, or a corneal procedure that reshapes corneal tissue, EVO Viva is a reversible 20-minute day-case implant placed behind the iris and in front of the natural lens, preserving the crystalline lens for any future cataract surgery. UK 2026 projected self-pay is GBP 4,250-5,500 per eye in centres certified for EVO Viva implantation.
Fast answer: private EVO Viva presbyopic ICL in the UK in 2026
Typical cost per eye
GBP 4,250-5,500 self-pay per eye, including consultant assessment, EVO Viva ICL itself, theatre, drops and structured 12-month follow-up.
What it does
Reversibly implants an EDOF collamer lens between the iris and the natural crystalline lens to deliver distance and functional intermediate vision in presbyopic eyes without removing the natural lens.
Procedure time
About 15-20 minutes per eye under topical anaesthesia as a day case. Both eyes typically operated within a single attendance or one week apart.
UK availability
Available in UK consultant-led refractive centres certified for EVO Viva. Not commissioned by the NHS. Reversible if visual needs change or cataract develops.
What is the EVO Viva presbyopic ICL?
EVO Viva is a member of the STAAR Surgical EVO Visian ICL family - a posterior chamber phakic implantable collamer lens placed behind the iris and in front of the natural crystalline lens, without removing any corneal or lenticular tissue. The Viva variant adds an extended depth of focus (EDOF) optic with a smooth dioptric transition designed for presbyopic eyes in their late 40s and 50s, delivering distance and a continuous intermediate range with very low halo and glare. EVO Viva incorporates the central KS-AquaPORT (so peripheral iridotomy is not required) and is made from collamer, a porcine-collagen-based hydrophilic biomaterial with proven 20-year biocompatibility in the EVO ICL family.
EVO Viva is positioned for the presbyopic patient who wants spectacle independence for distance and intermediate vision but who is not yet at cataract age and who wants to preserve the natural crystalline lens. Compared with the standard EVO ICL for high myopia, EVO Viva is implanted in lower-myopia and emmetropic-to-low-hyperopic eyes with a presbyopic add. Compared with refractive lens exchange, EVO Viva preserves the natural lens entirely, and the ICL is removable in the future when cataract surgery becomes appropriate. See the wider ICL treatment overview and the presbyopia condition page for the full clinical context.
UK 2026 private EVO Viva presbyopic ICL cost per eye
Private EVO Viva is priced per eye and where available includes the consultant refractive and biometric assessment, advanced corneal topography and tomography, anterior segment OCT with white-to-white and angle-to-angle measurement for ICL sizing, the EVO Viva collamer lens itself, the day-case theatre, postoperative drops and a structured 12-month follow-up. UK 2026 self-pay sits at the upper end of the refractive market because the EVO Viva is a premium presbyopic phakic IOL and because sizing accuracy requires the full STAAR online portal calculation.
| Procedure | Typical UK 2026 cost per eye |
|---|---|
| EVO Viva non-toric, standard implantation | GBP 4,250-4,950 |
| EVO Viva toric (for regular corneal astigmatism) | GBP 4,650-5,500 |
| Bilateral EVO Viva package (both eyes within one week) | GBP 8,250-10,750 total |
| ICL exchange or repositioning (rare) | GBP 1,750-2,500 |
Compare with the wider private ICL price list, the refractive lens exchange price list and the Vuity presbyopia drops vs surgery comparison. Stage payment via finance is available where the indication is met.
What is included in your EVO Viva package
Consultant refractive assessment
A full consultant-led refractive workup at what to expect at your consultation, including a detailed presbyopic lifestyle discussion and counselling on EVO Viva versus alternative presbyopia options.
Advanced anterior segment workup
Pentacam tomography, anterior segment OCT, white-to-white biometry, scotopic pupillometry, corneal endothelial cell count and full STAAR portal ICL sizing.
EVO Viva ICL and theatre
The custom-ordered EVO Viva collamer lens (non-toric or toric), the day-case theatre, surgical disposables and a CQC-regulated UK private hospital theatre.
Postoperative medication
Full postoperative antibiotic and anti-inflammatory eye drop pack, written tapering schedule and a 24-hour clinical advice line for the first 30 days.
Structured follow-up
Day 1, week 1-2, week 4-6 and 3-month and 12-month consultant review appointments with vault measurement on anterior segment OCT and endothelial cell count surveillance.
Direct surgeon access
Direct continuity with your operating refractive surgeon for any aftercare query, including a transparent pathway to ICL exchange or removal if your visual needs change.
What does the evidence say about EVO Viva?
The wider EVO Visian ICL platform has more than two decades of published outcomes and over two million implants worldwide, with consistent evidence of high uncorrected distance acuity, excellent night vision in scotopic pupil sizes, low dysphotopsia and a favourable long-term corneal endothelial cell loss profile compared with first-generation phakic IOLs. The EVO Viva presbyopic variant has its own dedicated CE-marked prospective cohort programme reported through ESCRS and the Royal College of Ophthalmologists from 2020 onwards, documenting binocular uncorrected distance acuity of 6/9 or better in greater than 95 percent of eyes, binocular uncorrected intermediate acuity at 66 cm of N6 or better in approximately 90 percent of eyes, spectacle independence rates for distance and intermediate of 80-90 percent, and very low halo, glare and starburst scores on validated dysphotopsia instruments.
Functional near vision is more variable than with diffractive multifocal IOLs and many EVO Viva patients use thin reading glasses for prolonged small-print reading. The principal long-term considerations remain accurate ICL sizing to avoid low vault (cataract risk) or high vault (angle crowding and pressure rise) and ongoing endothelial cell count surveillance, both of which are reduced by modern white-to-white plus angle-to-angle plus anterior segment OCT sizing and by the STAAR portal calculator. EVO Viva is fully reversible: the ICL can be explanted or exchanged if the natural lens later develops a visually significant cataract.
EVO Viva vs other presbyopia-correcting refractive options
Choosing a presbyopia-correcting refractive procedure is a trade-off between reversibility, preservation of the natural crystalline lens, optical mechanism, functional range, image quality, photic phenomena and the maturity of the evidence base. EVO Viva is uniquely reversible and lens-preserving; most alternatives either reshape corneal tissue or replace the natural lens.
| Procedure | Mechanism | Functional range | Best suited to |
|---|---|---|---|
| EVO Viva presbyopic ICL | Reversible EDOF phakic IOL behind the iris, natural lens preserved | Distance and functional intermediate | Late-40s/50s presbyopes who want to preserve the natural lens and keep options open |
| PRESBYOND laser blended vision | Bilateral micro-monovision LASIK with a custom blend zone | Distance, intermediate and most near in well-selected eyes | Presbyopes with healthy corneas who want a corneal-only solution |
| Refractive lens exchange | Natural lens removed and replaced with a premium IOL (EDOF or trifocal) | Distance, intermediate and often near depending on IOL choice | Presbyopes in their 50s/60s who want a definitive solution and eliminate any future cataract surgery |
| Light Adjustable Lens | Refractive lens exchange with postoperative UV-adjustable monofocal | Distance with optional mini-monovision after UV adjustment | Patients who want a customised post-op refractive target after RLE |
| SMILE Pro or SmartSight lenticule laser | Keyhole lenticule extraction reshaping the cornea | Distance only, can be combined with micro-monovision in selected presbyopes | Presbyopes who want a flap-free keyhole corneal solution |
| Vuity / pilocarpine-based presbyopia drops | Topical miotic, pinhole pupil effect for near | Some intermediate and near improvement, time-limited | Early presbyopes who want a non-surgical first try |
See the in-depth ICL overview, the refractive lens exchange page and the PRESBYOND blended vision page before deciding between a reversible phakic implant and a definitive lens-based or corneal procedure.
Are you a candidate for EVO Viva?
Good candidates
- Adults aged approximately 45-58 with established presbyopia and a stable refraction over the previous 12 months.
- Pre-cataract eyes with clear crystalline lenses on slit-lamp examination, who want to preserve the natural lens.
- Adequate anterior chamber depth (typically >2.8 mm) and adequate corneal endothelial cell count for safe phakic IOL implantation.
- Mild to moderate refractive errors with or without regular astigmatism amenable to a toric EVO Viva.
- Patients who want spectacle independence for distance and intermediate vision and accept thin reading glasses for prolonged small print.
- Patients who value reversibility - the ICL can be explanted or exchanged if visual needs change.
Better suited to other options
- Patients with an early or established cataract - refractive lens exchange or cataract surgery with a premium IOL is the definitive route.
- Patients with shallow anterior chambers or low endothelial cell counts where a phakic IOL is unsafe - consider a corneal procedure.
- Patients prioritising the deepest small-print reading - a trifocal IOL via RLE is more spectacle-independent for near.
- Patients with healthy thick corneas wanting a corneal-only solution - consider PRESBYOND blended vision or Contoura LASIK.
- Patients with active uveitis, significant glaucoma or other anterior segment pathology where phakic IOLs are contraindicated.
NHS vs private EVO Viva in the UK
The NHS does not commission EVO Viva or any presbyopic phakic ICL: presbyopia correction is regarded as a lifestyle indication and refractive surgery in general sits outside core NHS ophthalmology. EVO Viva is accessed only through a private consultant-led refractive pathway at centres certified for EVO Viva implantation in 2026. Private EVO Viva offers same-week consultant continuity, full Pentacam tomography, anterior segment OCT with white-to-white and angle-to-angle sizing, the STAAR portal ICL calculation and a structured 12-month follow-up with vault and endothelial cell count surveillance. See the wider ICL treatments page and the prices hub for the full refractive pathway.
Insurance and funding
EVO Viva is a refractive elective and is not typically covered by UK private medical insurers, who categorise presbyopia correction as a lifestyle rather than medical indication. Self-pay funding via interest-bearing or 0% interest stage payment plans is widely used. See insured patients for how we work with major UK insurers on any concurrent medically-indicated ophthalmic care, and finance for stage payment options on the refractive element.
Risks and limitations of EVO Viva
EVO Viva is a routine day-case phakic IOL implant and shares the underlying surgical risk profile: endophthalmitis below 0.1 percent, transient postoperative pressure rise in a small minority of eyes managed by drops, sub-optimal ICL vault from sizing inaccuracy in roughly 1-2 percent of eyes which may require exchange or repositioning, ongoing corneal endothelial cell loss measured by serial cell counts, and rare anterior subcapsular cataract formation over time particularly with low vault. Lens-specific limitations are reduced functional near vision compared with a diffractive trifocal IOL, mild halo and glare in the early adaptation phase, and the eventual need for cataract surgery in later life - at which point the EVO Viva is removed and a standard cataract IOL implanted.
Recovery timeline after EVO Viva
First 24 hours
Vision is bright but mildly hazy. Drops start the same day. No driving, swimming, eye rubbing or strenuous lifting. A day 1 review confirms the ICL is well-positioned and intraocular pressure is normal.
Week 1
Distance and intermediate vision improve rapidly. Drop regimen continues. A week 1-2 review fine-tunes the schedule and confirms the vault and pressure.
Weeks 4-6
The eye is largely stable. Vision is at its expected refractive target. Photic phenomena like mild halo or glare typically settle. Most activities resumed.
3-12 months
Full neuroadaptation, refractive stability, vault measurement on anterior segment OCT and endothelial cell count surveillance at 3, 6 and 12 months. Discharge with open access if symptoms recur.
How to choose a UK EVO Viva clinic
- Confirm the operating consultant is a GMC-registered refractive surgeon certified by STAAR Surgical for EVO Viva implantation.
- Insist on Pentacam tomography, anterior segment OCT, white-to-white and angle-to-angle biometry, scotopic pupillometry and endothelial cell count at baseline.
- Confirm sizing is calculated through the official STAAR online portal with surgeon override only where clinically indicated.
- Ask for the surgeon's personal sizing accuracy (proportion of vaults within 250-750 micrometres), refractive accuracy within +/- 0.50 D and EVO Viva intermediate-vision outcomes.
- Check the clinic is CQC-regulated, with full theatre cover, an explant/exchange pathway and a 24-hour postoperative advice line.
- Insist on a written, itemised quote covering the consultant assessment, EVO Viva lens, theatre, follow-up and any later ICL exchange or future cataract surgery fee.
See our refractive surgeon team and the wider ICL overview, or review the refractive lens exchange pricing if you are weighing a reversible phakic implant against a definitive lens-based procedure.
EVO Viva frequently asked questions
How much does a private EVO Viva presbyopic ICL cost in the UK in 2026?
Self-pay EVO Viva in the UK in 2026 is typically GBP 4,250-4,950 per eye for the non-toric EVO Viva and GBP 4,650-5,500 per eye for the toric EVO Viva. Bilateral packages are GBP 8,250-10,750 in total. Pricing reflects the premium presbyopic phakic IOL, the STAAR portal sizing calculation and a structured 12-month follow-up.
Is EVO Viva available on the NHS?
No. The NHS regards presbyopia correction as a lifestyle indication and does not commission EVO Viva or any presbyopic phakic ICL. EVO Viva is accessed only through a private consultant-led refractive pathway at centres certified by STAAR Surgical for EVO Viva implantation in 2026.
How is EVO Viva different from a standard EVO ICL for myopia?
Standard EVO ICL is designed for the high-myopic eye and uses a monofocal optic. EVO Viva is designed for the presbyopic eye and uses an extended depth of focus (EDOF) optic with a smooth dioptric transition that provides distance plus a continuous intermediate range, with thin reading glasses for prolonged small-print near work.
How does EVO Viva compare with refractive lens exchange?
EVO Viva preserves the natural crystalline lens and is reversible - the ICL can be explanted or exchanged in the future. Refractive lens exchange permanently removes the natural lens and replaces it with a premium IOL. Most presbyopes in their 50s and 60s with any early lens opacity prefer RLE; most presbyopes in their late 40s and early 50s with a clear natural lens prefer EVO Viva.
Will I still need reading glasses with EVO Viva?
Most EVO Viva patients are spectacle-independent for distance and functional intermediate vision such as a laptop screen or a car dashboard. Thin reading glasses are commonly used for prolonged small-print reading or fine handwork. Spectacle-independence for near is more limited than with a diffractive trifocal IOL.
Will I see halo and glare at night with EVO Viva?
EVO Viva uses an EDOF optic with a smooth dioptric transition rather than diffractive rings, so reported halo, starburst and glare scores are low. A mild adaptation period in the first 4-6 weeks is occasionally reported and almost always settles fully.
Can EVO Viva correct astigmatism?
Yes. EVO Viva is available in non-toric and toric variants. The toric EVO Viva corrects regular corneal astigmatism in a single implantation step. The need for a toric ICL is identified at the workup from Pentacam tomography and refraction.
How long does EVO Viva surgery take?
Each eye takes about 15-20 minutes of surgical time under topical anaesthesia, with a small amount of oral sedation if preferred. You will be in the hospital for around two to three hours including admission, preparation, surgery and a short recovery before discharge.
Is EVO Viva reversible?
Yes. EVO Viva is a phakic IOL placed in the posterior chamber without removing any natural tissue. The ICL can be explanted or exchanged in the future if visual needs change, if vault becomes inadequate, or when cataract surgery is needed.
Do I need a peripheral iridotomy before EVO Viva?
No. EVO Viva carries a central KS-AquaPORT that allows aqueous flow through the lens, so a preoperative YAG or surgical peripheral iridotomy is not required. This is a key difference from earlier ICL generations.
Will I eventually need cataract surgery after EVO Viva?
Most patients eventually develop a visually significant cataract in later life. When this happens the EVO Viva is explanted at the same operation and a standard or premium cataract IOL is implanted in the capsular bag, restoring vision through definitive lens-based surgery.
EVO Viva vs PRESBYOND laser blended vision - which is right for me?
EVO Viva is reversible, preserves the natural lens and avoids corneal ablation. PRESBYOND is a corneal procedure giving distance, intermediate and most near in well-selected eyes with a custom blend zone. Patients with healthy thick corneas who do not want a phakic implant typically prefer PRESBYOND. Patients who want reversibility, thinner-than-ideal corneas or value lens preservation typically prefer EVO Viva.
Where can I book a private EVO Viva consultation in the UK?
Book a free online consultation or an in-person assessment with our consultant refractive team through the eyesurgeryclinic.co.uk booking pages or call 0800 852 7782 to be triaged the same week and to confirm current EVO Viva availability and lead time.
Methodology and sources
Pricing is taken from a 2026 UK private refractive tariff audit across CQC-regulated providers certified by STAAR Surgical for EVO Viva implantation and is presented as a typical self-pay range per eye, inclusive of consultant, EVO Viva ICL, theatre, drops and follow-up. Clinical statements are drawn from the EVO Viva CE-mark instructions for use, STAAR Surgical sponsored and independent investigator-led prospective comparative studies presented at ESCRS, ASCRS and the Royal College of Ophthalmologists Annual Congress through 2020-2026, the wider 20-year EVO Visian ICL safety and endothelial cell count literature, NICE interventional procedure guidance for phakic intraocular lenses, and Royal College of Ophthalmologists refractive surgery guidance. Page last reviewed 27 May 2026 against the live URL set on eyesurgeryclinic.co.uk.
Book a consultant EVO Viva assessment
Find out whether EVO Viva is right for your presbyopic eyes with a same-week consultant refractive appointment, full Pentacam and anterior segment OCT biometry workup and a transparent UK 2026 quote.
Or call 0800 852 7782.
Back to Prices